The scientific discovery of a genetic code called CRISPR could help eradicate diseases in humans forever, but could altering genes become a slippery slope?
There are over 6,000 known human genetic disorders, with more being discovered and named every day. At the time of writing this, only 10 percent of them are treatable.
Genetic diseases can reduce quality of life, cause chronic pain, and shorten lifespan drastically, which is why the quest to identify cures has been central to health research throughout history.
Many are caused by a single strand mutation in human DNA which is made up of 3 billion. This is all very scientific, so just imagine a dictionary with one letter in one word misspelled, causing the publishers to cancel and reprint the entire edition of the book.
Thatβs how random, influential, and possibly detrimental a single altered strand in DNA can be to human health. This also gives an idea of why experts in genealogy have been working tirelessly to figure out a way to alter or repair genomes since their discovery.
Since the 1990s, science has led to some incredible breakthroughs – but few have been as exciting as the discovery of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats). Now try saying that five times, fast.
Scientists discovered that certain bacteria have CRISPR, specialised gaps in their DNA which allow them to store the genetic code of viruses once theyβre encountered. Next time the virus tries to attack, the bacteria recognise the virus and remain unaffected – in short, it has gained immunity.
Though still in its therapeutic stages, scientists can theoretically use CRISPR to edit the DNA mutation in a human suffering from a genetic disease.
CRISPR commands the personβs DNA to snip a piece of its own mutated code to make room to learn the virusβ DNA, meaning the person is less impacted by or immune to a disease forever.
Using this method, virus immunity will be limited to that individual only. The personβs immunity would not be passed onto their children and would also not alter the genetic code of future generations in any way.
Hereβs where things get a little tricky.
In the quest to optimise human health and eradicate diseases for good, scientists have questioned if CRISPR could be carried out in the earliest stages of human development – preventing such diseases from emerging in the first place.
If the genetic code for a disease (like Sickle Cell, for example) was inserted into an embryo, the child would have natural immunity to the disease from the beginning of its growth.
But the adult born from that embryo would also pass that immunity to their child, and their childβs child, and onward – altering the gene pool forever. It would be fantastic if we could genetically modify immunity for diseases like Cystic Fibrosis, Huntingtonβs Disease, or Haemophilia so that no babies were born with them ever again. Right?
Some scientists donβt seem to think so. First because the method hasnβt been deemed safe for human trial yet and also, because weβd be messing with the natural world.
But that didnβt stop He Jiankui, a scientist working at a university in China from giving it a shot.
Jiankui was the first person to use CRISPR to give a human embryo the gene for HIV immunity. A man using IVF to reproduce with his partner was positive for the virus and wanted to eliminate the possibility of passing the gene onto his children.
Following the procedure, Jiankui reported two babies were born from the embryo and were perfectly healthy. That said, they remain anonymous to this day.
Though it wasnβt illegal at the time, the ethics behind Jiankuiβs actions were subject to global criticism. For forging documents and unethical conduct, Jiankui was placed under surveillance by his laboratory and ultimately landed three years in prison, as well as a fine of almost half a million USD.
Jiankuβs trial may have been successful, but across the board, most experts donβt believe that CRISPR is ready to be used outside of therapeutic stages for already-born human beings.
At the same time, the possibility that CRISPR could eventually diminish the prevalence of genetic diseases when used in embryos lingers in the minds of the medical community.
Could gene editing go too far?
Itβs only natural to question what else gene editing could be used for.
If scientists perfect the method of altering DNA belonging unborn children to eliminate disease, what else could they change?Β Eye and hair colour, height, muscular strength, and face shape are traits that scientists currently view as plausible.
When the technology surrounding CRISPR inevitably advances, genetically engineering unborn children to make βdesigner babiesβ could move into mainstream culture in the future – something couples discuss over their takeaway dinner.
However, many bioethicists link gene editing for aesthetic reasons to eugenics, the practice of improving the genetic quality of humans based on beliefs that some physical traits are superior to others.
Forgive me for even saying this, but you must consider that if an extreme political leader β letβs say Hitler, for example – got his hands on CRISPR eighty years ago, the entire human population might be white skinned with blonde hair and blue eyes right now.
Is the whole point of reproduction not to diversify the human species, to create a broad range of characteristics, and to help humans evolve naturally? If we start altering the appearance of our children, we could risk having a highly homogenous gene pool in the future.
Not to mention, it would be likely that only the wealthiest would have access to these technologies, which would only further already existing socio-economic disparities.
And although genetic diseases lead to immense human suffering around the world, could eliminating them completely mean overpopulating the planet at a rate faster than we already are?
Science still has quite a way to go before CRISPR can be used safely and efficiently for these reasons. But when it inevitably happens, these will be ethical questions the science world will need to grapple with.
Until then, you decide – could advancing gene-editing technology for medical reasons become a slippery slope? And what other consequences could it have for our future?
Iβm Jessica (She/Her). I’m the Deputy Editor & Content Partnership Manager at Thred. Originally from the island of Bermuda, I specialise in writing about ocean health and marine conservation, but you can also find me delving into pop culture, health and wellness, plus sustainability in the beauty and fashion industries. Follow me on Twitter, LinkedIn and drop me some ideas/feedback via email.
As we review the digital habits of the last few years and question what they might look like going forward, several factors point to a future in which we arenβt quite so wrapped up in the virtual world.
Isnβt it strange to recall a time when social media didnβt exist?
For the past decade, weβve watched as platform after platform has materialised, some cementing themselves at the heart of our digital...
Amidst tabloid speculations of the declining health of Sunita Williams and Butch Wilmore, NASA has stepped in to rebut the claims and reassure the public about the good health of the astronauts.
2024 was proven unfruitful for Boeing amidst multiple safety concerns about its planes and ongoing lawsuits. In current news, its nightmares have also gone beyond our atmosphere with the company facing delays in the return of astronauts Suni...
Itβs long been theorised that giving thanks can cultivate a stronger desire to be giving. Now, thereβs neuroscience to back this up, with recent research revealing a link between a grateful brain and an altruistic one.
If youβre into mindfulness, then youβll know how transformative it can be to practice gratitude.
Actually, even if youβre not into all that self-reflection stuff, Iβm sure that at one point or another youβve noticed...
The DRCβs lawyers have stated that tech giant Apple has knowingly sourced minerals from conflict zones in East Africa while publicly painting itself as sustainable and ethical. Β
The Democratic Republic of Congo has filed lawsuits in both Paris and Brussels claiming that tech-giant Apple purchased illegal βblood mineralsβ from its conflict zones for use in its product lines.
Filed against the Apple European subsidiaries, the lawsuit states that the company...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok